Is Determination of Prostatic Acid Phosphatase in Bone Marrow by Radioimmunoassay (BM-PAP) Useful in Patients with Prostatic Cancer?
Prostatic acid phosphatase (PAP) determined in serum and bone marrow, is claimed to be a useful tumour marker in prostatic carcinoma (1,2,3,4). The clinical significance of bone marrow PAP (BM-PAP) has, however, not been clearly defined, possibly due to methodological problems of BM-PAP analysis.
KeywordsBone Marrow Bone Metastasis Acid Phosphatase Prostatic Carcinoma Prostatic Acid Phosphatase
Unable to display preview. Download preview PDF.
- 5.UICC, TNM pre-treatment clinical classification. TNM classification of malignant tumours. Third edition, 119 (1978), Geneva.Google Scholar
- 8.A. Skinningsrud, K. Nustad, S.D. Fossa, M. Aas and J.H.N. Syversen, Immunoassay of human prostatic acid phosphatase, Scand. J. clin. lab. Invest. 39:46 (1979).Google Scholar
- 9.A. Skinningsrud and K. Nustad, Prostatic acid phosphatase purification and iodination with iodogen, Clin. Chim. Acta. (1981) In press.Google Scholar